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Hypoglycemia is the most common but preventable metabolic abnormality in neonates. Prolong neonatal hypoglycemia may result in irreversible brain damage, 
mental retardation, recurrent seizure activity, personality disorders, 
and even death. The pathological changes are characterized by 
atrophic gyri, reduced myelination, and atrophy of cerebral white 
matter [1]. Blood glucose is essential for normal neurological 
function and development. Poor reserve of liver glycogen and 
fat and immature metabolic pathway at birth predisposes preterm 
and small for gestational age (SGA) neonates to prolonged 
hypoglycemia[1-3]. In perinatal asphyxia, high fuel requirement 
of anaerobic metabolism, the depletion of stores, and a delay 
in metabolic adaptation are possible underlying mechanisms of 
hypoglycemia. Neonatal hyperinsulinism and hypoglycemia 
occur in infants of diabetic mothers (IDMs). Other known 
causes of neonatal hypoglycemia are islet cell dysregulation 
syndrome (nesidioblastosis), Beckwith–Wiedemann syndrome, 
insulin-secreting adenoma, congenital hypopituitarism, glycogen 
storage diseases, defects of amino acids metabolism, defects of 
gluconeogenesis, and defects of β-oxidation of fatty acids [4-6].
The definition of hypoglycemia in the newborn has remained 
controversial due to lack of significant correlation between 
plasma glucose concentration, clinical symptoms, and its 
long-term sequelae [7]. Hypoglycemia is defined as a glucose 
concentration two standard deviations below the mean of a 
particular population. In healthy term neonates, serum glucose 
values are rarely  <35 mg/dl between 1 and 3 h of life, <40 mg/dl 
from 3 to 24 h, and <45 mg/dl after 24 h [8,9]. The incidence 
of hypoglycemia varies with definition, population, method, 
and timing of feeding and the type of glucose assay. The overall 
incidents vary from 1 to 5/1000 live birth, but it has been estimated 
to occur in up to 16% of large for gestational age (LGA) neonates 
and 15% of SGA neonates and 5–10% in preterm neonates [8,10].
Neonatal hypoglycemia is a subject to be reexplored as 
the relation between plasma glucose concentration, clinical 
symptoms, and its long-term sequelae is poorly understood, 
controversies exist over its best way of detection, despite 
increase in institutional deliveries and advances in neonatal care 
practices neonatal hypoglycemia continues to occur. This study 
was taken up to find out the proportion of neonates developing 
hypoglycemia in the neonatal intensive care unit (NICU) and to 
study the clinical profile of hypoglycemia in neonates.
MATERIALS AND METHODS
This hospital-based cross-sectional study was conducted in the 
NICU, Department of Pediatrics in a tertiary care teaching hospital 
of Agartala over a period from November 2015 to August 2017. 
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Neonates admitted within 2 h of life in inborn and outborn NICU 
during the study period consisted of the study population. The sample 
size was determined using the following formula suitable for cross-
sectional clinical studies[11], N=Z2 P (1–P)/d2; where, N = minimum 
sample score; Z = Standard normal deviate value corresponding 
to 95% confidence interval (=1.96); P = Estimated prevalence 
(29% prevalence was used [12]), d = degree of precision (set=5%). 
Therefore, N=1.962 × 0.29 (1–0.29)/0.0025 = 316. Questionnaires, 
patient profile records, and investigation reports were the study tools. 
The study was carried out after approval from the institutional ethical 
committee. Written informed consent from the parents was taken 
before recruiting the neonate into the study.
All term and preterm neonates admitted in inborn and outborn 
NICU within 2 h of delivery during the study period were included 
in the study. Neonates, with gross congenital malformations which 
are life threatening or have the potential to result in disability and 
neonates whose parents did not consent for inclusion in the study, 
were excluded from the study. All term and preterm neonates 
admitted in inborn and outborn NICU within 2 h of delivery 
during the study period were screened for hypoglycemia after 
getting informed consent from the parents/guardians.
After thorough hand wash, pre-warmed sole was pricked 
with a sterile lancet. A drop of blood was collected to the curved 
edge of the test strip to completely cover the yellow color on the 
strip. Test result was read within 30 sec. For the study purpose, 
operational threshold for hypoglycemia was defined as random 
blood sugar <40 mg/dl for both initial 48 h and beyond [13]. 
Blood sugar was screened just before feeding by Accutrend-alpha 
glucometer at 2, 6, 12, 24, 48, and 72 h of age and/or whenever 
symptoms suggestive of hypoglycemia developed. For critically 
sick neonate such as those with perinatal asphyxia, sepsis, and 
shock, blood sugar was screened every 6 h in active phase of the 
illness.
Accutrend-alpha glucometer worked on the principle of 
bio-amperometry and had a sensitivity of 98% and specificity 
of 93% for detecting neonatal hypoglycemia (<40 mg/dl) with 
a positive predictive value of 88% and negative predictive 
value of 99% [14,15]. For babies who showed blood sugar 
level <40 ml/dl, a second blood sample was sent to laboratory 
immediately for estimation of whole blood sugar levels and 
hypoglycemia managed according to the standard treatment 
protocol [16]. A detailed history for all cases was taken with 
emphasis on the antenatal, natal, and postnatal events. Thorough 
clinical examination including general physical examination and 
systemic examination was done. In addition, required samples 
were also sent for relevant investigations from diagnosis and 
management point of view depending on the case.
In asymptomatic babies, oral feeds were given and blood 
sugar tested after 30 min, if repeat blood sugar was >40 mg/dl, 
2 hourly feeding was given with 6 hourly monitoring of blood 
sugar for 48 h. If repeat blood sugar value was still <40 mg/dl, 
I.V. glucose infusion at 6 mg/kg/min was started. In symptomatic 
babies, an intravenous (IV) bolus of 2 ml/kg of 10% dextrose was 
given followed by glucose infusion at 6 mg/kg/min. Blood sugar 
checked after 30 min. If the blood sugar value still was <40 mg/dl, 
glucose infusion was increased at 2 mg/kg/min and blood sugar 
rechecked after 30 min. Once blood sugar level was maintained 
>40 mg/dl and then blood sugar level was checked at 2 h. After 24 
h of IV glucose therapy, once two consecutive blood sugar levels 
were >40 mg/dl, the infusion was tapered off at 2 mg/kg/min every 
6 h with blood sugar level monitoring. Tapering was accompanied 
by concomitant increase in oral feeds. Once a rate of 4 mg/kg/min 
of glucose infusion was achieved and oral feeding was adequate 
and the blood sugar level was consistently >40 mg/dl, the infusion 
was stopped. In cases of refractory hypoglycemia (hypoglycemia 
persisting beyond 7 days of life despite glucose infusion rates of 
12 mg/kg/min for >24), hydrocortisone, diazoxide, octreotide, 
and glucagon were used [16].
Data were recorded, compiled, and analyzed with computer 
using the SPSS version 15.0. Raw data were grouped as per 
neonatal risk factors such as gestational age, birth weight, and 
as per intrauterine growth curve, and maternal risk factors such 
as maternal diabetes mellitus, eclampsia, premature rupture of 
membrane (PROM), antenatal steroid, chorioamnionitis, mode of 
delivery, and maternal fever. Statistical tests such as χ2 test and 
Fisher’s exact test were used as per applicability. p<0.05 was 
considered as statistically significant.
RESULTS
In the present study, of 320 neonates admitted in NICU, 
103 (32.2%) neonates developed at least one episode of 
hypoglycemia during the hospital stay. Of 320 newborn enrolled 
in the study, 168 (58.1%) were male and 134 (41.9%) were 
female. Out of these, 35% of the male neonates and 27.6% of 
the female neonates had hypoglycemia. Majority (64%) of the 
hypoglycemic episodes occurred within 24 h of life. Another 28% 
of the hypoglycemic episode occurred between 24 and 72 h of 
life. Only 8% of the hypoglycemic episode occurred beyond 72 h 
of life.
A total of 61.5% of preterm babies (gestational 
age <37 weeks) and 15.3% of term neonates developed 
hypoglycemia (p<0.0001). The incidence of hypoglycemia is 
also significantly higher in neonates with birth weight <2.5 kg 
(56.7%) or >4 kg (73.6%) than in neonates with normal 
birth weight (p=0.0000). Furthermore, hypoglycemia was 
significantly more among SGA (45%) and LGA (63.2%) babies 
in comparison to appropriate for gestational age (AGA) babies 
(p=0.0000). Besides, the incidence of hypoglycemia was more 
in asphyxiated babies (48.3%) than in non-asphyxiated babies 
(22.5%) (p<0.0001) as shown in Table 1.
Significantly higher incidence of hypoglycemia was found 
in IDMs (66.7%) than in neonates born to non-diabetic mothers 
(26.1%) (p=0.000). However, no significant difference was 
found with respect to the presence or absence of maternal fever, 
PROM, eclampsia, maternal IV fluids, antenatal corticosteroid, 
history of chorioamnionitis, and mode of delivery (Table 2). In 
the present study, 11% of cases of the documented hypoglycemia 
were asymptomatic. Among the symptomatic cases, the leading 
symptoms found were lethargy (45.63%), convulsion (20.38%), 
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apnea (9.71%), jitteriness (7.76%), and hypothermia (5.82%) in 
descending order of frequency.
DISCUSSION
In this study, the incidence of neonatal hypoglycemia was 32.2% 
among the neonates admitted in NICU. Osier et al. [17], in 2003, 
from Kenya, Sasidharan et al. [18], in 2004, from Kerala, India, 
Lodhi et al. [12], in 2006, from India, Dashti et al. [19], in 2007, 
from Tehran, De et al. [20], in 2011, from Kolkata, India, and 
Singh et al. [21], in 2014, from Manipur, India, reported the 
prevalence of neonatal hypoglycemia as 23%, 4.1%, 29.1%, 
15.1%, 32.6%, and 15.2%, respectively. Our finding is similar to 
that of Lodhi et al. [12] and De et al. [20]
In our study, 64% of the hypoglycemic episodes occurred 
within 24 h of life. Bhat et al. [22], in 2000, Sasidharan et al. [18], 
in 2005, and Ayoub et al. [8], in 2013 reported that 98%, 65.6%, 
and 62.5% neonates develop hypoglycemia during the 1st day of 
life, respectively. Our observation is close to that of Sasidharan 
et al. [18] and Ayoub et al. [8].We also observed that neonatal 
hypoglycemia between 24 and 72 h of life developed in 28% of 
cases and beyond 72 h, in 8% of babies. Ayoub et al. [8] reported 
that 31.1% of the neonates developed hypoglycemia between 24 
and 72 h of life and 6.2% after 72 h of life. Our observation is in 
close proximity to that of Ayoub et al. [8].
Hypoglycemia was found among 58.1% of male and 41.9% 
of female neonates in this series. Singh et al. [21] also found male 
predominance of hypoglycemia (16.99% in male vs. 13.33% in 
female). Similar results have also been reported by Hamid and 
Chishti from Pakistan [23]. Hypoglycemia was more common 
in preterm newborns (61.5%) than in newborns with gestational 
age >37 weeks (15.3%) in the present study. Singh et al. [21] reported 
hypoglycemia in 19.05% of preterm and 14.42% of term neonates. 
Burdan et al. [24] reported hypoglycemia in 52.8% preterm and 
45.53% term neonates. De et al. [20] found that 77.77% of preterm 
and 22.95% of term neonates had hypoglycemia. All these studies 
demonstrated a preponderance of hypoglycemia in preterm neonates.
In the present series, hypoglycemia was more commonly 
seen in newborns with birth weight <2.5 kg and >4 kg than in 
normal birth weight babies (p=0.000). Similarly, De et al. [20] 
found higher incidence of hypoglycemia in low birth weight 
(LBW) babies than in normal birth weight babies (64% vs. 14%, 
respectively). Bhand et al. [25] also found that 26% LBW babies 
had hypoglycemia. In this study, hypoglycemia was more in SGA 
and LGA neonates than in AGA neonates (p=0.00). Ho et al. [26] 
from Malaysia reported a higher incidence of hypoglycemia in 
SGA (34.2%) than in AGA neonates (16.6%). Burdan et al. [24] 
also reported more hypoglycemia (45.16%) in SGA than in AGA 
neonates (33.66%). Similar observations were also made by 
Dhananjaya and Kiran [27] and De et al. [20] in their studies.
In the present study, a higher incidence of hypoglycemia 
was observed in IDMs (p<0.001). Similar results were found 
in the studies conducted by Dhananjaya and Kiran [27] and 
Sasidharan et al. [18] and they also reported significantly higher 
incidence of hypoglycemia in neonates born to diabetic mother. 
On the contrary, Bhand et al. [25] observed lower incidence of 
hypoglycemia (13%) in neonates born to diabetic mother. This 
difference might be due to difference in the study design.
Table 1: Distribution of NH in relation to neonatal variables
Parameters Hypoglycemia (%) No hypoglycemia (%) p value
Gestational 
age (weeks)
≥37 31 (15.3) 172 (84.7) <0.0001
<37 72 (61.5) 45 (38.5)
Birth weight (kg)
<2.5 55 (56.7) 42 (43.3) <0.0001
2.5–4 34 (16.7) 170 (83.3)
>4 14 (73.6) 5 (26.3)
Gestational age
SGA 50 (45) 61 (55) <0.0001
AGA 41 (21.5) 149 (78.4)
LGA 12 (63.2) 7 (36.8)
Birth asphyxia
Present 58 (48.3) 62 (51.7) <0.0001
Absent 45 (22.5) 155 (77.5)
SGA: Small for gestational age, AGA: Appropriate for gestational age, LGA: Large 
for gestational age. NH: Neonatal hyperbilirubinemia
Table 2: Distribution of NH in relation to maternal variables
Maternal 
variables
Hypoglycemia (%) No hypoglycemia (%) p value
Diabetes mellitus
Present 32 (66.7) 16 (33.3) <0.0001
Absent 71 (26.1) 201 (73.9)
Eclampsia
Present 7 (53.8) 6 (46.2) 0.1263
Absent 96 (31.3) 211 (68.7)
PROM
Present 9 (45) 11 (55) 0.2217 
Absent 94 (31.3) 206 (68.7)
Antenatal 
steroid
Present 30 (25.6) 87 (74.4) 0.0630
Absent 73 (36) 130 (64)
Chorioamnionitis
Present 2 (22.2) 7 (77.8) 0.7256
Absent 101 (32.5) 210 (67.5)
Mode of 
delivery
Vaginal 42 (27.8) 109 (72.2) 0.1207
LSCS 61 (36) 108 (64)
Maternal fever
Present 8 (53.3) 7 (46.7) 0.0902
Absent 95 (31.1) 210 (68.8)
Received IV 
fluids
Present 33 (25.8) 95 (74.2) 0.0510
Absent 70 (36.5) 122 (63.5)
PROM: Premature rupture of membrane, LSCS: Lower segment cesarean section. 
NH: Neonatal hyperbilirubinemia, IV: Intravenous
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Other maternal factors including maternal fever, PROM, 
eclampsia, IV fluids, antenatal corticosteroid, chorioamnionitis, 
and mode of delivery did not show a significant difference in the 
incidence of hypoglycemia in their neonates. Similarly, Ayoub 
et al. [8] found that maternal hypertension was not a risk factor for 
hypoglycemia. On the contrary, Sasidharan et al. [18] reported a 
higher incidence of hypoglycemia in babies (50%) of mother with 
eclampsia. This difference might be due to difference in sample 
size. Pettit et al. [28] reported a higher rate of hypoglycemia 
in neonates exposed to antenatal steroid (5.7% vs. 4.2%). This 
difference might be due to the difference in sample size and study 
design.
In this study, a higher incidence of hypoglycemia was observed 
in neonates with birth asphyxia (p<0.0001). Other studies have 
shown a variable incidence of hypoglycemia in birth asphyxia 
ranging from 57.1% in a study done by Sasidharan et al. [18] to 
as low as 15% in a study done by Babu et al. [29]. Moreover, as 
many as, 11% of cases of the documented hypoglycemia were 
asymptomatic in the present study. Among the symptomatic 
cases, the leading symptoms found were lethargy (45.63%) 
and convulsion (20.38%). Singhal et al. [30] observed lethargy 
(81.4%), jitteriness (67.4%), respiratory abnormality (41.9%), 
hypotonia (39.5%), seizure (30.2%), and cyanosis (18.6%) in 
decreasing order of frequency. Many other studies have shown 
similar observations.
CONCLUSION
The present study showed the incidence of hypoglycemia as 
32.2% among the neonates admitted in NICU. The proportion 
of hypoglycemia was more in neonates with prematurity, birth 
asphyxia, maternal diabetes mellitus, and in LGA and SGA 
neonates. It was also observed that hypoglycemia occurred more 
commonly within 24 h of life. Lethargy, convulsion, apnea, and 
jitteriness were the common presenting symptom.
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